APO Research
Talk to an analyst

APO RESEARCH · REPORT

HER2 ADC Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global HER2 ADC Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025198 pages

Choose your research edition.

Industry ResearchHER2 ADC Drugs Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal HER2 ADC Drugs Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal HER2 ADC Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal HER2 ADC Drugs Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal HER2 ADC Drugs Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global HER2 ADC Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for HER2 ADC Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for HER2 ADC Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for HER2 ADC Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for HER2 ADC Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of HER2 ADC Drugs include CSPC Pharmaceutical Group, Hengrui Pharmaceuticals, BioNTech(Yingen Biopharmaceutical), Biokin Pharmaceutical, Takeda, RemeGen, MacroGenics, Genentech, Inc.(Roche) and Daiichi Sankyo, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global HER2 ADC Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of HER2 ADC Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents HER2 ADC Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the HER2 ADC Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

HER2 ADC Drugs Segment by Company

CSPC Pharmaceutical Group

Hengrui Pharmaceuticals

BioNTech(Yingen Biopharmaceutical)

Biokin Pharmaceutical

Takeda

RemeGen

MacroGenics

Genentech, Inc.(Roche)

Daiichi Sankyo

AstraZeneca

HER2 ADC Drugs Segment by Type

RC48（Disitamab vedotin）

T-DM1（Kadcyla，Trastuzumab emtansine）

T-DXd（DS-8201，Enhertu，Trastuzumab deruxtecan）

HER2 ADC Drugs Segment by Application

Hospitals

Clinic

Others

HER2 ADC Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HER2 ADC Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of HER2 ADC Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HER2 ADC Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the HER2 ADC Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of HER2 ADC Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of HER2 ADC Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of HER2 ADC Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. HER2 ADC Drugs Industry Trends Table 2. HER2 ADC Drugs Industry Drivers Table 3. HER2 ADC Drugs Industry Opportunities and Challenges Table 4. HER2 ADC Drugs Industry Restraints Table 5. Global HER2 ADC Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global HER2 ADC Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global HER2 ADC Drugs Sales by Manufacturers (K G) & (2021-2026) Table 8. Global HER2 ADC Drugs Sales Market Share by Manufacturers Table 9. Global HER2 ADC Drugs Average Sales Price (US$/K G) of Manufacturers (2021-2026) Table 10. Global HER2 ADC Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global HER2 ADC Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global HER2 ADC Drugs Manufacturers, Product Type & Application Table 13. Global HER2 ADC Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global HER2 ADC Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of RC48（Disitamab vedotin） Table 17. Major Manufacturers of T-DM1（Kadcyla，Trastuzumab emtansine） Table 18. Major Manufacturers of T-DXd（DS-8201，Enhertu，Trastuzumab deruxtecan） Table 19. Global HER2 ADC Drugs Sales by Type 2021 VS 2025 VS 2032 (K G) Table 20. Global HER2 ADC Drugs Sales by Type (2021-2026) & (K G) Table 21. Global HER2 ADC Drugs Sales by Type (2027-2032) & (K G) Table 22. Global HER2 ADC Drugs Sales Market Share by Type (2021-2026) Table 23. Global HER2 ADC Drugs Sales Market Share by Type (2027-2032) Table 24. Global HER2 ADC Drugs Revenue by Type 2021 VS 2025 VS 2032 (K G) Table 25. Global HER2 ADC Drugs Revenue by Type (2021-2026) & (K G) Table 26. Global HER2 ADC Drugs Revenue by Type (2027-2032) & (K G) Table 27. Global HER2 ADC Drugs Revenue Market Share by Type (2021-2026) Table 28. Global HER2 ADC Drugs Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospitals Table 30. Major Manufacturers of Clinic Table 31. Major Manufacturers of Others Table 32. Global HER2 ADC Drugs Sales by Application 2021 VS 2025 VS 2032 (K G) Table 33. Global HER2 ADC Drugs Sales by Application (2021-2026) & (K G) Table 34. Global HER2 ADC Drugs Sales by Application (2027-2032) & (K G) Table 35. Global HER2 ADC Drugs Sales Market Share by Application (2021-2026) Table 36. Global HER2 ADC Drugs Sales Market Share by Application (2027-2032) Table 37. Global HER2 ADC Drugs Revenue by Application 2021 VS 2025 VS 2032 (K G) Table 38. Global HER2 ADC Drugs Revenue by Application (2021-2026) & (K G) Table 39. Global HER2 ADC Drugs Revenue by Application (2027-2032) & (K G) Table 40. Global HER2 ADC Drugs Revenue Market Share by Application (2021-2026) Table 41. Global HER2 ADC Drugs Revenue Market Share by Application (2027-2032) Table 42. Global HER2 ADC Drugs Sales by Region: 2021 VS 2025 VS 2032 (K G) Table 43. Global HER2 ADC Drugs Sales by Region (2021-2026) & (K G) Table 44. Global HER2 ADC Drugs Sales Market Share by Region (2021-2026) Table 45. Global HER2 ADC Drugs Sales Forecasted by Region (2027-2032) & (K G) Table 46. Global HER2 ADC Drugs Sales Forecasted Market Share by Region (2027-2032) Table 47. North America HER2 ADC Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K G) Table 48. North America HER2 ADC Drugs Sales by Country (2021-2026) & (K G) Table 49. North America HER2 ADC Drugs Sales by Country (2027-2032) & (K G) Table 50. Europe HER2 ADC Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K G) Table 51. Europe HER2 ADC Drugs Sales by Country (2021-2026) & (K G) Table 52. Europe HER2 ADC Drugs Sales by Country (2027-2032) & (K G) Table 53. Asia Pacific HER2 ADC Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K G) Table 54. Asia Pacific HER2 ADC Drugs Sales by Country (2021-2026) & (K G) Table 55. Asia Pacific HER2 ADC Drugs Sales by Country (2027-2032) & (K G) Table 56. South America, Middle East and Africa HER2 ADC Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K G) Table 57. South America, Middle East and Africa HER2 ADC Drugs Sales by Country (2021-2026) & (K G) Table 58. South America, Middle East and Africa HER2 ADC Drugs Sales by Country (2027-2032) & (K G) Table 59. Global HER2 ADC Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global HER2 ADC Drugs Revenue by Region (2021-2026) & (US$ Million) Table 61. Global HER2 ADC Drugs Revenue by Region (2027-2032) & (US$ Million) Table 62. Global HER2 ADC Drugs Revenue Market Share by Region (2021-2026) Table 63. Global HER2 ADC Drugs Revenue Market Share by Region (2027-2032) Table 64. CSPC Pharmaceutical Group Company Information Table 65. CSPC Pharmaceutical Group Business Overview Table 66. CSPC Pharmaceutical Group HER2 ADC Drugs Sales (K G), Price (US$/K G), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. CSPC Pharmaceutical Group HER2 ADC Drugs Product Portfolio Table 68. CSPC Pharmaceutical Group Recent Development Table 69. Hengrui Pharmaceuticals Company Information Table 70. Hengrui Pharmaceuticals Business Overview Table 71. Hengrui Pharmaceuticals HER2 ADC Drugs Sales (K G), Price (US$/K G), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Hengrui Pharmaceuticals HER2 ADC Drugs Product Portfolio Table 73. Hengrui Pharmaceuticals Recent Development Table 74. BioNTech(Yingen Biopharmaceutical) Company Information Table 75. BioNTech(Yingen Biopharmaceutical) Business Overview Table 76. BioNTech(Yingen Biopharmaceutical) HER2 ADC Drugs Sales (K G), Price (US$/K G), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. BioNTech(Yingen Biopharmaceutical) HER2 ADC Drugs Product Portfolio Table 78. BioNTech(Yingen Biopharmaceutical) Recent Development Table 79. Biokin Pharmaceutical Company Information Table 80. Biokin Pharmaceutical Business Overview Table 81. Biokin Pharmaceutical HER2 ADC Drugs Sales (K G), Price (US$/K G), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Biokin Pharmaceutical HER2 ADC Drugs Product Portfolio Table 83. Biokin Pharmaceutical Recent Development Table 84. Takeda Company Information Table 85. Takeda Business Overview Table 86. Takeda HER2 ADC Drugs Sales (K G), Price (US$/K G), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Takeda HER2 ADC Drugs Product Portfolio Table 88. Takeda Recent Development Table 89. RemeGen Company Information Table 90. RemeGen Business Overview Table 91. RemeGen HER2 ADC Drugs Sales (K G), Price (US$/K G), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. RemeGen HER2 ADC Drugs Product Portfolio Table 93. RemeGen Recent Development Table 94. MacroGenics Company Information Table 95. MacroGenics Business Overview Table 96. MacroGenics HER2 ADC Drugs Sales (K G), Price (US$/K G), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. MacroGenics HER2 ADC Drugs Product Portfolio Table 98. MacroGenics Recent Development Table 99. Genentech, Inc.(Roche) Company Information Table 100. Genentech, Inc.(Roche) Business Overview Table 101. Genentech, Inc.(Roche) HER2 ADC Drugs Sales (K G), Price (US$/K G), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Genentech, Inc.(Roche) HER2 ADC Drugs Product Portfolio Table 103. Genentech, Inc.(Roche) Recent Development Table 104. Daiichi Sankyo Company Information Table 105. Daiichi Sankyo Business Overview Table 106. Daiichi Sankyo HER2 ADC Drugs Sales (K G), Price (US$/K G), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Daiichi Sankyo HER2 ADC Drugs Product Portfolio Table 108. Daiichi Sankyo Recent Development Table 109. AstraZeneca Company Information Table 110. AstraZeneca Business Overview Table 111. AstraZeneca HER2 ADC Drugs Sales (K G), Price (US$/K G), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. AstraZeneca HER2 ADC Drugs Product Portfolio Table 113. AstraZeneca Recent Development Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. HER2 ADC Drugs Distributors List Table 117. HER2 ADC Drugs Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. HER2 ADC Drugs Product Image Figure 2. Global HER2 ADC Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global HER2 ADC Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global HER2 ADC Drugs Sales (2021-2032) & (K G) Figure 5. Global HER2 ADC Drugs Average Price (US$/K G) & (2021-2032) Figure 6. Global Top 5 and 10 HER2 ADC Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. RC48（Disitamab vedotin） Image Figure 9. T-DM1（Kadcyla，Trastuzumab emtansine） Image Figure 10. T-DXd（DS-8201，Enhertu，Trastuzumab deruxtecan） Image Figure 11. Global HER2 ADC Drugs Sales by Type (2021 VS 2025 VS 2032) & (K G) Figure 12. Global HER2 ADC Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global HER2 ADC Drugs Sales Market Share by Type (2021-2032) Figure 14. Global HER2 ADC Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K G) Figure 15. Global HER2 ADC Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global HER2 ADC Drugs Revenue Market Share by Type (2021-2032) Figure 17. Hospitals Image Figure 18. Clinic Image Figure 19. Others Image Figure 20. Global HER2 ADC Drugs Sales by Application (2021 VS 2025 VS 2032) & (K G) Figure 21. Global HER2 ADC Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global HER2 ADC Drugs Sales Market Share by Application (2021-2032) Figure 23. Global HER2 ADC Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K G) Figure 24. Global HER2 ADC Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global HER2 ADC Drugs Revenue Market Share by Application (2021-2032) Figure 26. North America HER2 ADC Drugs Sales and Growth Rate (2021-2032) & (K G) Figure 27. North America HER2 ADC Drugs Sales Market Share by Country (2021-2032) Figure 28. U.S. HER2 ADC Drugs Sales and Growth Rate (2021-2032) & (K G) Figure 29. Canada HER2 ADC Drugs Sales and Growth Rate (2021-2032) & (K G) Figure 30. Mexico HER2 ADC Drugs Sales and Growth Rate (2021-2032) & (K G) Figure 31. Europe HER2 ADC Drugs Sales and Growth Rate (2021-2032) & (K G) Figure 32. Europe HER2 ADC Drugs Sales Market Share by Country (2021-2032) Figure 33. Germany HER2 ADC Drugs Sales and Growth Rate (2021-2032) & (K G) Figure 34. France HER2 ADC Drugs Sales and Growth Rate (2021-2032) & (K G) Figure 35. U.K. HER2 ADC Drugs Sales and Growth Rate (2021-2032) & (K G) Figure 36. Italy HER2 ADC Drugs Sales and Growth Rate (2021-2032) & (K G) Figure 37. Netherlands HER2 ADC Drugs Sales and Growth Rate (2021-2032) & (K G) Figure 38. Asia Pacific HER2 ADC Drugs Sales and Growth Rate (2021-2032) & (K G) Figure 39. Asia Pacific HER2 ADC Drugs Sales Market Share by Country (2021-2032) Figure 40. China HER2 ADC Drugs Sales and Growth Rate (2021-2032) & (K G) Figure 41. Japan HER2 ADC Drugs Sales and Growth Rate (2021-2032) & (K G) Figure 42. South Korea HER2 ADC Drugs Sales and Growth Rate (2021-2032) & (K G) Figure 43. Southeast Asia HER2 ADC Drugs Sales and Growth Rate (2021-2032) & (K G) Figure 44. India HER2 ADC Drugs Sales and Growth Rate (2021-2032) & (K G) Figure 45. Australia HER2 ADC Drugs Sales and Growth Rate (2021-2032) & (K G) Figure 46. South America, Middle East and Africa HER2 ADC Drugs Sales and Growth Rate (2021-2032) & (K G) Figure 47. South America, Middle East and Africa HER2 ADC Drugs Sales Market Share by Country (2021-2032) Figure 48. Brazil HER2 ADC Drugs Sales and Growth Rate (2021-2032) & (K G) Figure 49. South Africa HER2 ADC Drugs Sales and Growth Rate (2021-2032) & (K G) Figure 50. Saudi Arabia HER2 ADC Drugs Sales and Growth Rate (2021-2032) & (K G) Figure 51. Turkey HER2 ADC Drugs Sales and Growth Rate (2021-2032) & (K G) Figure 52. Argentina HER2 ADC Drugs Sales and Growth Rate (2021-2032) & (K G) Figure 53. UAE HER2 ADC Drugs Sales and Growth Rate (2021-2032) & (K G) Figure 54. Egypt HER2 ADC Drugs Sales and Growth Rate (2021-2032) & (K G) Figure 55. Chile HER2 ADC Drugs Sales and Growth Rate (2021-2032) & (K G) Figure 56. Global HER2 ADC Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global HER2 ADC Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America HER2 ADC Drugs Revenue (2021-2032) & (US$ Million) Figure 59. North America HER2 ADC Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe HER2 ADC Drugs Revenue (2021-2032) & (US$ Million) Figure 61. Europe HER2 ADC Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific HER2 ADC Drugs Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific HER2 ADC Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa HER2 ADC Drugs Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa HER2 ADC Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. HER2 ADC Drugs Value Chain Figure 67. Manufacturing Cost Structure Figure 68. HER2 ADC Drugs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • RC48（Disitamab vedotin）
  • T-DM1（Kadcyla，Trastuzumab emtansine）
  • T-DXd（DS-8201，Enhertu，Trastuzumab deruxtecan）
Applications
  • Hospitals
  • Clinic
  • Others
Companies covered
  • CSPC Pharmaceutical Group
  • Hengrui Pharmaceuticals
  • BioNTech(Yingen Biopharmaceutical)
  • Biokin Pharmaceutical
  • Takeda
  • RemeGen
  • MacroGenics
  • Genentech, Inc.(Roche)
  • Daiichi Sankyo
  • AstraZeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global HER2 ADC Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global HER2 ADC Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global HER2 ADC Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global HER2 ADC Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global HER2 ADC Drugs Market Dynamics
  1. 2.1 HER2 ADC Drugs Industry Trends
  2. 2.2 HER2 ADC Drugs Industry Drivers
  3. 2.3 HER2 ADC Drugs Industry Opportunities and Challenges
  4. 2.4 HER2 ADC Drugs Industry Restraints
3 HER2 ADC Drugs Market by Manufacturers
  1. 3.1 Global HER2 ADC Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global HER2 ADC Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global HER2 ADC Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global HER2 ADC Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global HER2 ADC Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global HER2 ADC Drugs Manufacturers, Product Type & Application
  7. 3.7 Global HER2 ADC Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global HER2 ADC Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 HER2 ADC Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 HER2 ADC Drugs Tier 1, Tier 2, and Tier 3
4 HER2 ADC Drugs Market by Type
  1. 4.1 HER2 ADC Drugs Type Introduction
  2. 4.1.1 RC48（Disitamab vedotin）
  3. 4.1.2 T-DM1（Kadcyla，Trastuzumab emtansine）
  4. 4.1.3 T-DXd（DS-8201，Enhertu，Trastuzumab deruxtecan）
  5. 4.2 Global HER2 ADC Drugs Sales by Type
  6. 4.2.1 Global HER2 ADC Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global HER2 ADC Drugs Sales by Type (2021-2032)
  8. 4.2.3 Global HER2 ADC Drugs Sales Market Share by Type (2021-2032)
  9. 4.3 Global HER2 ADC Drugs Revenue by Type
  10. 4.3.1 Global HER2 ADC Drugs Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global HER2 ADC Drugs Revenue by Type (2021-2032)
  12. 4.3.3 Global HER2 ADC Drugs Revenue Market Share by Type (2021-2032)
5 HER2 ADC Drugs Market by Application
  1. 5.1 HER2 ADC Drugs Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global HER2 ADC Drugs Sales by Application
  6. 5.2.1 Global HER2 ADC Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global HER2 ADC Drugs Sales by Application (2021-2032)
  8. 5.2.3 Global HER2 ADC Drugs Sales Market Share by Application (2021-2032)
  9. 5.3 Global HER2 ADC Drugs Revenue by Application
  10. 5.3.1 Global HER2 ADC Drugs Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global HER2 ADC Drugs Revenue by Application (2021-2032)
  12. 5.3.3 Global HER2 ADC Drugs Revenue Market Share by Application (2021-2032)
6 Global HER2 ADC Drugs Sales by Region
  1. 6.1 Global HER2 ADC Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global HER2 ADC Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global HER2 ADC Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global HER2 ADC Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America HER2 ADC Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America HER2 ADC Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe HER2 ADC Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe HER2 ADC Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific HER2 ADC Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific HER2 ADC Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa HER2 ADC Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa HER2 ADC Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global HER2 ADC Drugs Revenue by Region
  1. 7.1 Global HER2 ADC Drugs Revenue by Region
  2. 7.1.1 Global HER2 ADC Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global HER2 ADC Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global HER2 ADC Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global HER2 ADC Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America HER2 ADC Drugs Revenue (2021-2032)
  8. 7.2.2 North America HER2 ADC Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe HER2 ADC Drugs Revenue (2021-2032)
  11. 7.3.2 Europe HER2 ADC Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific HER2 ADC Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific HER2 ADC Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa HER2 ADC Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa HER2 ADC Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 CSPC Pharmaceutical Group
  2. 8.1.1 CSPC Pharmaceutical Group Company Information
  3. 8.1.2 CSPC Pharmaceutical Group Business Overview
  4. 8.1.3 CSPC Pharmaceutical Group HER2 ADC Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 CSPC Pharmaceutical Group HER2 ADC Drugs Product Portfolio
  6. 8.1.5 CSPC Pharmaceutical Group Recent Developments
  7. 8.2 Hengrui Pharmaceuticals
  8. 8.2.1 Hengrui Pharmaceuticals Company Information
  9. 8.2.2 Hengrui Pharmaceuticals Business Overview
  10. 8.2.3 Hengrui Pharmaceuticals HER2 ADC Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Hengrui Pharmaceuticals HER2 ADC Drugs Product Portfolio
  12. 8.2.5 Hengrui Pharmaceuticals Recent Developments
  13. 8.3 BioNTech(Yingen Biopharmaceutical)
  14. 8.3.1 BioNTech(Yingen Biopharmaceutical) Company Information
  15. 8.3.2 BioNTech(Yingen Biopharmaceutical) Business Overview
  16. 8.3.3 BioNTech(Yingen Biopharmaceutical) HER2 ADC Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 BioNTech(Yingen Biopharmaceutical) HER2 ADC Drugs Product Portfolio
  18. 8.3.5 BioNTech(Yingen Biopharmaceutical) Recent Developments
  19. 8.4 Biokin Pharmaceutical
  20. 8.4.1 Biokin Pharmaceutical Company Information
  21. 8.4.2 Biokin Pharmaceutical Business Overview
  22. 8.4.3 Biokin Pharmaceutical HER2 ADC Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Biokin Pharmaceutical HER2 ADC Drugs Product Portfolio
  24. 8.4.5 Biokin Pharmaceutical Recent Developments
  25. 8.5 Takeda
  26. 8.5.1 Takeda Company Information
  27. 8.5.2 Takeda Business Overview
  28. 8.5.3 Takeda HER2 ADC Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Takeda HER2 ADC Drugs Product Portfolio
  30. 8.5.5 Takeda Recent Developments
  31. 8.6 RemeGen
  32. 8.6.1 RemeGen Company Information
  33. 8.6.2 RemeGen Business Overview
  34. 8.6.3 RemeGen HER2 ADC Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 RemeGen HER2 ADC Drugs Product Portfolio
  36. 8.6.5 RemeGen Recent Developments
  37. 8.7 MacroGenics
  38. 8.7.1 MacroGenics Company Information
  39. 8.7.2 MacroGenics Business Overview
  40. 8.7.3 MacroGenics HER2 ADC Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 MacroGenics HER2 ADC Drugs Product Portfolio
  42. 8.7.5 MacroGenics Recent Developments
  43. 8.8 Genentech, Inc.(Roche)
  44. 8.8.1 Genentech, Inc.(Roche) Company Information
  45. 8.8.2 Genentech, Inc.(Roche) Business Overview
  46. 8.8.3 Genentech, Inc.(Roche) HER2 ADC Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Genentech, Inc.(Roche) HER2 ADC Drugs Product Portfolio
  48. 8.8.5 Genentech, Inc.(Roche) Recent Developments
  49. 8.9 Daiichi Sankyo
  50. 8.9.1 Daiichi Sankyo Company Information
  51. 8.9.2 Daiichi Sankyo Business Overview
  52. 8.9.3 Daiichi Sankyo HER2 ADC Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Daiichi Sankyo HER2 ADC Drugs Product Portfolio
  54. 8.9.5 Daiichi Sankyo Recent Developments
  55. 8.10 AstraZeneca
  56. 8.10.1 AstraZeneca Company Information
  57. 8.10.2 AstraZeneca Business Overview
  58. 8.10.3 AstraZeneca HER2 ADC Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 AstraZeneca HER2 ADC Drugs Product Portfolio
  60. 8.10.5 AstraZeneca Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 HER2 ADC Drugs Value Chain Analysis
  2. 9.1.1 HER2 ADC Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 HER2 ADC Drugs Production Mode & Process
  6. 9.2 HER2 ADC Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 HER2 ADC Drugs Distributors
  9. 9.2.3 HER2 ADC Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst